Rapid Quality Assessment of Ceftriaxone Using Near-Infrared Spectroscopy.

James T Isaacs, Philip J Almeter, Aaron N Hunter, Thomas A Lyman, Stephanie P Zapata, Bradley S Henderson, Seth A Larkin, Eleonora Hasani, Uiyeol Yoon, Adler Crumrin, Jerod Smith, Spencer Pergrem, Ashton Plymale, Bailee Ramnes, Joshua D Melson, Jeffrey W Reynolds, Ryan W Naseman, Thomas L Platt, Robert A Lodder
{"title":"Rapid Quality Assessment of Ceftriaxone Using Near-Infrared Spectroscopy.","authors":"James T Isaacs, Philip J Almeter, Aaron N Hunter, Thomas A Lyman, Stephanie P Zapata, Bradley S Henderson, Seth A Larkin, Eleonora Hasani, Uiyeol Yoon, Adler Crumrin, Jerod Smith, Spencer Pergrem, Ashton Plymale, Bailee Ramnes, Joshua D Melson, Jeffrey W Reynolds, Ryan W Naseman, Thomas L Platt, Robert A Lodder","doi":"10.6084/m9.figshare.28593284","DOIUrl":null,"url":null,"abstract":"<p><p>Ceftriaxone for injection, USP is a sterile, semisynthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular administration. Ceftriaxone sodium is a white to yellowish crystalline powder which is readily soluble in water, sparingly soluble in methanol and very slightly soluble in ethanol. The color of ceftriaxone sodium solutions ranges from light yellow to amber, depending on the length of storage, concentration and diluent used. Each vial contains ceftriaxone sodium equivalent to 250 mg, 500 mg, 1 gram or 2 grams of ceftriaxone activity. Ceftriaxone sodium contains approximately 83 mg (3.6 mEq) of sodium per gram of ceftriaxone activity. Intra-lot variability was detected in the spectra of 6 vials of ceftriaxone sampled from one lot. One of the vials was more than 8.3 multidimensional SDs away from the center of the cluster of the other 5 vials from the same lot, suggesting that the manufacturing process may not be in a state of control. Interlot variability was detected between two lots of the drug using a subcluster detection test (r<sub>tn</sub>=0.9629, r<sub>ts</sub>=0.9148, p=0.02).</p>","PeriodicalId":72698,"journal":{"name":"Contact in context","volume":"2025 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970922/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contact in context","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6084/m9.figshare.28593284","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Ceftriaxone for injection, USP is a sterile, semisynthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular administration. Ceftriaxone sodium is a white to yellowish crystalline powder which is readily soluble in water, sparingly soluble in methanol and very slightly soluble in ethanol. The color of ceftriaxone sodium solutions ranges from light yellow to amber, depending on the length of storage, concentration and diluent used. Each vial contains ceftriaxone sodium equivalent to 250 mg, 500 mg, 1 gram or 2 grams of ceftriaxone activity. Ceftriaxone sodium contains approximately 83 mg (3.6 mEq) of sodium per gram of ceftriaxone activity. Intra-lot variability was detected in the spectra of 6 vials of ceftriaxone sampled from one lot. One of the vials was more than 8.3 multidimensional SDs away from the center of the cluster of the other 5 vials from the same lot, suggesting that the manufacturing process may not be in a state of control. Interlot variability was detected between two lots of the drug using a subcluster detection test (rtn=0.9629, rts=0.9148, p=0.02).

近红外光谱快速评价头孢曲松的质量。
注射用头孢曲松(USP)是一种无菌、半合成、广谱的头孢菌素类抗生素,用于静脉注射或肌肉注射。头孢曲松钠为白色至淡黄色结晶粉末,易溶于水,难溶于甲醇,极微溶于乙醇。头孢曲松钠溶液的颜色范围从浅黄色到琥珀色,取决于储存时间、浓度和使用的稀释剂。每瓶含有相当于250毫克,500毫克,1克或2克头孢曲松活性的头孢曲松钠。头孢曲松钠每克头孢曲松活性含有约83毫克(3.6毫当量)的钠。在同一批次取样的6瓶头孢曲松的光谱中检测到批次内变异。其中一个小瓶与来自同一批次的其他5个小瓶的簇中心距离超过8.3多维标准差,表明生产过程可能处于不可控状态。采用亚簇检测试验检测两批药物的批次间变异性(rtn=0.9629, rts=0.9148, p=0.02)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信